• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于小肠中肽递送的气体驱动药物递送系统的研发

Development of a Gas Empowered Drug Delivery system for peptide delivery in the small intestine.

作者信息

Sadeghi A M M, Avadi M R, Ejtemaimehr Sh, Abashzadeh Sh, Partoazar A, Dorkoosh F, Faghihi M, Rafiee-Tehrani M, Junginger H E

机构信息

Division of Pharmaceutical Technology, Leiden University, P.O. Box 9502, 2300RA Leiden, The Netherlands.

出版信息

J Control Release. 2009 Feb 20;134(1):11-7. doi: 10.1016/j.jconrel.2008.10.012. Epub 2008 Oct 26.

DOI:10.1016/j.jconrel.2008.10.012
PMID:19014985
Abstract

The aim of this investigation was to design a novel Gas Empowered Drug Delivery (GEDD) system for CO(2) forced transport of peptide drugs together with mucoadhesive polymers to the surface of the small intestine. The GEDD effect of the core tablet was achieved using CO(2) gas to push insulin together with the mucoadhesive excipients poly(ethyleneoxide) (PEO) and the permeation enhancer trimethyl chitosan (TMC) to the surface of the small intestine. The in-vitro insulin release showed that almost 100% of the insulin was released from enterically coated tablets within 30 min at pH 6.8. The designed GEDD system was shown to increase the insulin transport by approximately 7 times in comparison with the free insulin across sheep's intestine ex-vivo. Three different peroral formulations were administered to male rabbits: F1 containing no TMC or PEO, F2 containing PEO but no TMC and F3 containing both PEO and TMC. The administrations of insulin using the formulation F1 resulted in a low FR value of 0.2%+/-0.1%, while the formulations F2 and F3 resulted in a much higher FR values of 0.6+/-0.2% and 1.1%+/-0.4%, respectively. Hence, the insulin permeation achieved by the GEDD system is primarily due to the enhancing effect of TMC and the mucoadhesive properties of PEO both of which synergistically increase the bioavailability of insulin.

摘要

本研究的目的是设计一种新型气体驱动药物递送(GEDD)系统,用于将肽类药物与粘膜粘附聚合物一起通过二氧化碳强制运输至小肠表面。通过使用二氧化碳气体将胰岛素与粘膜粘附辅料聚环氧乙烷(PEO)和渗透促进剂三甲基壳聚糖(TMC)推至小肠表面,实现了核心片剂的GEDD效应。体外胰岛素释放表明,在pH 6.8条件下,肠溶包衣片在30分钟内几乎100%释放胰岛素。与游离胰岛素相比,所设计的GEDD系统在离体羊肠中使胰岛素转运增加了约7倍。将三种不同的口服制剂给予雄性兔子:F1不含TMC或PEO,F2含PEO但不含TMC,F3同时含PEO和TMC。使用制剂F1给药胰岛素导致低FR值为0.2%±0.1%,而制剂F2和F3的FR值分别高得多,为0.6±0.2%和1.1%±0.4%。因此,GEDD系统实现的胰岛素渗透主要归因于TMC的增强作用和PEO的粘膜粘附特性,二者协同提高了胰岛素的生物利用度。

相似文献

1
Development of a Gas Empowered Drug Delivery system for peptide delivery in the small intestine.用于小肠中肽递送的气体驱动药物递送系统的研发
J Control Release. 2009 Feb 20;134(1):11-7. doi: 10.1016/j.jconrel.2008.10.012. Epub 2008 Oct 26.
2
Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs.三甲基化壳聚糖作为聚合物吸收促进剂用于改善肽类药物的口服给药
Eur J Pharm Biopharm. 2004 Sep;58(2):225-35. doi: 10.1016/j.ejpb.2004.03.023.
3
Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.壳聚糖及其衍生物的渗透促进作用:作为可溶性聚合物和纳米颗粒系统的制剂对Caco-2细胞中胰岛素吸收的比较。
Eur J Pharm Biopharm. 2008 Sep;70(1):270-8. doi: 10.1016/j.ejpb.2008.03.004. Epub 2008 Mar 12.
4
Effects of absorption promoters on insulin absorption through colon-targeted delivery.吸收促进剂对胰岛素经结肠靶向给药吸收的影响。
Int J Pharm. 2006 Jan 13;307(2):156-62. doi: 10.1016/j.ijpharm.2005.09.028. Epub 2005 Nov 9.
5
Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.月桂基琥珀酰壳聚糖颗粒用于口服胰岛素递送与吸收的合成及评价
J Control Release. 2009 Apr 17;135(2):144-51. doi: 10.1016/j.jconrel.2009.01.011.
6
Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.巯基化三甲基壳聚糖纳米粒在口服胰岛素递送中的药物渗透性和粘膜粘附特性
Biomaterials. 2009 Oct;30(29):5691-700. doi: 10.1016/j.biomaterials.2009.06.055. Epub 2009 Jul 16.
7
Thiolated chitosan: development and in vitro evaluation of an oral delivery system for acyclovir.巯基化壳聚糖:阿昔洛韦口服给药系统的研发及体外评价
Int J Pharm. 2008 Feb 4;348(1-2):54-60. doi: 10.1016/j.ijpharm.2007.07.004. Epub 2007 Jul 10.
8
Nasal and rectal delivery of insulin with chitosan and N-trimethyl chitosan chloride.壳聚糖和 N-三甲基壳聚糖盐酸盐经鼻腔和直肠给药的胰岛素。
Drug Deliv. 2010 Aug;17(6):399-407. doi: 10.3109/10717541003762888.
9
Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport.用于口服胰岛素传递的杯状细胞靶向纳米颗粒,以及黏液对胰岛素传递的影响。
Biomaterials. 2012 Feb;33(5):1573-82. doi: 10.1016/j.biomaterials.2011.10.075. Epub 2011 Nov 16.
10
Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies.壳聚糖溶液中鼻腔胰岛素给药:体外和体内研究
Int J Pharm. 2004 Aug 20;281(1-2):11-23. doi: 10.1016/j.ijpharm.2004.05.007.

引用本文的文献

1
A Cyclodextrin-Based Controlled Release System in the Simulation of In Vitro Small Intestine.基于环糊精的控释系统在体外模拟小肠中的应用。
Molecules. 2020 Mar 7;25(5):1212. doi: 10.3390/molecules25051212.
2
Designing the new generation of intelligent biocompatible carriers for protein and peptide delivery.设计用于蛋白质和肽递送的新一代智能生物相容性载体。
Acta Pharm Sin B. 2018 Mar;8(2):147-164. doi: 10.1016/j.apsb.2018.01.013. Epub 2018 Mar 2.
3
A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives.
蛋白质和肽类口服给药策略及其临床前景综述。
Saudi Pharm J. 2016 Jul;24(4):413-28. doi: 10.1016/j.jsps.2014.06.004. Epub 2014 Jun 16.
4
Development of bioadhesive chitosan superporous hydrogel composite particles based intestinal drug delivery system.基于生物黏附性壳聚糖超高孔水凝胶复合粒子的肠道药物传递系统的开发。
Biomed Res Int. 2013;2013:563651. doi: 10.1155/2013/563651. Epub 2013 Aug 4.